CINCINNATI — Procter & Gamble’s Prilosec OTC brand has teamed up with two of the National Football League’s toughest offensive lineman to highlight the importance of powerful protection when treating frequent heartburn.
P&G said Tuesday that New York Giants offensive tackle David Diehl and Minnesota Vikings guard Anthony Herrera will be part of the Prilosec OTC "Living Proof" campaign to share their heartburn protection stories this NFL season.
Just as these players offer strong protection for their teams on the line, Prilosec OTC provides 24-hour protection against frequent heartburn with one pill a day. Herrera said he "anticipates heartburn when hunched over the O-line or when enjoying his favorite spicy foods." According to Diehl, he is affected by heartburn "most of his day and has to adjust his eating habits to compensate," but he knows that the one thing that can’t change is his on-field performance.
The Prilosec OTC Living Proof campaign will feature Diehl and Herrera’s stories on http://www.prilosecotc.com and will be supported by television and digital advertising also featuring the players. Throughout the season, both linemen will share their personal experiences with heartburn and how managing it has had a positive impact on their game.
"David Diehl and Anthony Herrera are living proof that heartburn can happen to even the toughest people," commented Phil McWaters, Prilosec OTC brand manager. "These players will help people understand that frequent heartburn doesn’t have to get in the way of their daily activities and that Prilosec OTC can them help manage and protect against it."
Consumers also can visit PrilosecOTC.com to get more information about Diehl and Herrera’s Prilosec OTC partnership and to take their own 14-day Living Proof challenge.
Prilosec OTC can work for 24 hours with one pill a day by directly shutting down many acid pumps in the stomach when used as directed for 14 days for the treatment of frequent heartburn. The heartburn medication is available over-the-counter through an alliance between P&G and AstraZeneca.
